fda bulk list exclusion

FDA to exclude semaglutide, tirzepatide and liraglutide on 503B bulks list — Photo by Nataliya Vaitkevich on Pexels

Experts Warn Semaglutide Pricing Shifts Hidden

Experts Warn Semaglutide Pricing Shifts Hidden Semaglutide prices are projected to rise about 25% after the FDA removed it from the 503B bulk list. The rule change forces pharmacists to buy the drug at manufacturer price, which cascades into higher co-pays and tighter health-system budgets. In my work consulting with